Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS and ADXSD) (the “Company”), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced an updated business outlook for 2013, which includes the development of its clinical strategy to advance its lead product candidate, ADXS-HPV, to registrational trials. The Company has also generated additional encouraging data and continues to strengthen its financial position.
Help employers find you! Check out all the jobs and post your resume.
